Tirzepatide noninferior, superior to semaglutide for T2DM
(HealthDay)—The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, tirzepatide, is noninferior and superior to semaglutide for reducing glycated hemoglobin levels among patients ...
Jun 29, 2021
0
4